Hanover J A, Willingham M C, Pastan I
Ann N Y Acad Sci. 1983;421:410-23. doi: 10.1111/j.1749-6632.1983.tb18135.x.
Recent studies in our laboratory have been aimed at biochemically characterizing the alpha 2M receptor present on fibroblast membranes. The approach we have taken is to develop a means of assessing binding to solubilized alpha 2M binding sites. The binding activity was not removed by treatment with high salt concentration or treatment with chaotropic agents. Removal of the binding activity from membranes did occur using a variety of detergents which suggests that the receptor molecules may be "intrinsic" membrane proteins. The most useful detergent for solubilizing the alpha 2M receptor was octyl-beta-D-glucoside. The alpha 2M binding activity could be removed from NRK fibroblasts and Vero cells using this detergent and was found to remain in solution at 100,000 X g. Removal of the octyl-beta-D-glucoside by extensive dialysis resulted in formation of protein-lipid aggregates that bind to 125I-alpha 2M specifically and with high affinity. Such binding sites were not generated when KB cells (which lack receptors) were extracted with the detergent. Significantly, the observed affinities detected for both high- and low-affinity binding sites were similar to those reported with intact cells or membranes. In addition, binding to the solubilized sites could be inhibited using compounds known to block the receptor-mediated endocytosis of alpha 2M (bacitracin, IBHNA). Other compounds (monensin, dansylcadaverine), which did not directly inhibit the high-affinity binding sites, may exert their effects at different stages in receptor-mediated endocytosis (i.e., receptor recycling). alpha 2M binding sites from NIH-3T3 (spontaneous) tumors have been purified approximately 95-fold by a combination of ion exchange and gel permeation chromatography. The receptor appears to be an acidic protein that approximately coelutes with aldolase (45 A, 158,000 daltons) on gel filtration. Ion exchange chromatography appears to remove an endogenous inhibitor of alpha 2M binding and may also remove binding sites having lower affinity for 125I-alpha 2M. Recent studies using immobilized alpha 2M as an affinity resin suggest that the high-affinity alpha 2M receptor may have a subunit molecular weight of approximately 85,000. Studies are now in progress aimed at further characterizing these high-affinity binding sites. Once bound to the alpha 2M receptor, alpha 2M enters cells via coated pits and is rapidly transferred to receptosomes. These organelles carry the ligand into the Golgi region, from which it is transferred to lysosomes where it is slowly degraded.(ABSTRACT TRUNCATED AT 400 WORDS)
我们实验室最近的研究旨在从生物化学角度对成纤维细胞膜上存在的α2M受体进行表征。我们采用的方法是开发一种评估与可溶性α2M结合位点结合的手段。用高盐浓度处理或用离液剂处理并不能去除结合活性。使用多种去污剂确实能从膜上去除结合活性,这表明受体分子可能是“内在”膜蛋白。用于溶解α2M受体最有效的去污剂是辛基-β-D-葡萄糖苷。使用这种去污剂可从NRK成纤维细胞和Vero细胞中去除α2M结合活性,并且发现其在100,000×g离心力下仍保留在溶液中。通过广泛透析去除辛基-β-D-葡萄糖苷会导致形成蛋白质-脂质聚集体,该聚集体能特异性且高亲和力地结合125I-α2M。用去污剂提取缺乏受体的KB细胞时不会产生这种结合位点。重要的是,观察到的高亲和力和低亲和力结合位点的亲和力与完整细胞或膜的报道相似。此外,已知可阻断α2M受体介导的内吞作用的化合物(杆菌肽、异丁基高半胱氨酸)可抑制与可溶性位点的结合。其他化合物(莫能菌素、丹磺酰尸胺)虽不直接抑制高亲和力结合位点,但可能在受体介导的内吞作用的不同阶段发挥作用(即受体再循环)。通过离子交换和凝胶渗透色谱相结合的方法,已将来自NIH-3T3(自发)肿瘤的α2M结合位点纯化了约95倍。该受体似乎是一种酸性蛋白,在凝胶过滤中与醛缩酶(45 A,158,000道尔顿)大致同时洗脱。离子交换色谱似乎能去除α2M结合的内源性抑制剂,也可能去除对125I-α2M亲和力较低的结合位点。最近使用固定化α2M作为亲和树脂的研究表明,高亲和力α2M受体的亚基分子量可能约为85,000。目前正在进行研究,旨在进一步表征这些高亲和力结合位点。一旦与α2M受体结合,α2M通过有被小窝进入细胞,并迅速转移至受体小体。这些细胞器将配体转运至高尔基体区域,从那里再转移至溶酶体,在溶酶体中它会被缓慢降解。(摘要截取自400字)